Výsledky vyhľadávania

Nájdených záznamov: 2  
Váš dotaz: Autor-kód záznamu = "^sllk_un_auth p0045859^"
  1. SYSr040673
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130619105742.7
    100
      
    $a 20070308a2006 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax $f S. Y. Kang ... [et al.]
    215
      
    $c obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2006_006_005 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 5 (2006), s. 450-456 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied
    541
    1-
    $a Súčasná chemorádioterapia u pacientov s rakovinou nosohltana: prognostický význam nízkej expresie bax $z slo
    606
    1-
    $a nádory nosohltana $x farmakoterapia $x rádioterapia $2 mesh $3 sllk_un_auth*d009303 $9 .
    606
    1-
    $a chemoterapia adjuvantná $x účinky nežiaduce $x využitie $2 mesh $3 sllk_un_auth*d017024 $9 .
    606
    1-
    $a terapia kombinovanými metódami $2 mesh $3 sllk_un_auth*d003131 $9 .
    606
    2-
    $a cisplatina $x použitie terapeutické $2 mesh $3 sllk_un_auth*d002945 $9 .
    606
    2-
    $a proteín X spojený s bcl-2 $2 mesh $3 sllk_un_auth*d051028 $9 .
    606
    2-
    $a expresia génu $2 mesh $3 sllk_un_auth*d015870 $9 .
    606
    2-
    $a prognóza $2 mesh $3 sllk_un_auth*d011379 $9 .
    610
    2-
    $a bax proteín
    610
    2-
    $a fluorouracil
    675
      
    $a 616.211/.327-006-085:615.277+615.849 $v 2. $z slo
    701
    -1
    $a Kang $b S. Y. $3 sllk_un_auth*p0047369 $4 070 $p Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Oh $b Y. T. $3 sllk_un_auth*p0045866 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Han $b J. H. $3 sllk_un_auth*p0047370 $4 070 $p Departments of Pathology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Choi $b J.-H. $3 sllk_un_auth*p0045861 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Lim $b H.-Y $3 sllk_un_auth*p0045862 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kim $b H. I. $3 sllk_un_auth*p0047371 $4 070 $p Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Lee $b H.-W. $3 sllk_un_auth*p0045859 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Jang $b J. H. $3 sllk_un_auth*p0047372 $4 070 $p Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Park $b J. S. $3 sllk_un_auth*p0045863 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kim $b H. C. $3 sllk_un_auth*p0045864 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kang $b S. $3 sllk_un_auth*p0045865 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Chun $b M. $3 sllk_un_auth*p0045867 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kim $b C. H. $3 sllk_un_auth*p0047373 $4 070 $p Departments of Otolaryngology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Joo $b H. J. $3 sllk_un_auth*p0047375 $4 070 $p Departments of Pathology, Ajou University Schol of Medicine, Suwon, Korea
    801
    -0
    $a SK $b BA006 $c 20070308 $g AACR2
  2. SYSr038764
    LBL
      
    ^^^^^naa^^22^^^^^^^^450
    005
      
    20161115132233.4
    100
      
    $a 20061023a2006 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a <The> addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer - single institution retrospective analysis $f H.-W. Lee ... [et al.]
    215
      
    $c grafy, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2006_006_001 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 1 (2006), s. 30-36 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied
    541
    1-
    $a Doplnok indukčnej chemoterapie s etopozidom, ifosfamidom a cisplatinou na zvýšenie úspešnosti súčasnej chemorádioterapie u pacientov s lokálne pokročilým nemalobunkovým nádorom pľúc - retrospektívna ústavná analýza $z slo
    606
    1-
    $a karcinóm pľúc, nemalobunkový $x farmakoterapia $x terapia $2 mesh $3 sllk_un_auth*d002289 $9 .
    606
    1-
    $a chemoterapia adjuvantná $2 mesh $3 sllk_un_auth*d017024 $9 .
    606
    1-
    $a farmakoterapia $x účinky nežiaduce $2 mesh $3 sllk_un_auth*d004358 $9 .
    606
    2-
    $a etopozid $x toxicita $x použitie terapeutické $2 mesh $3 sllk_un_auth*d005047 $9 .
    606
    2-
    $a ifosfamid $2 mesh $3 sllk_un_auth*d007069 $9 .
    606
    2-
    $a cisplatina $2 mesh $3 sllk_un_auth*d002945 $9 .
    606
    2-
    $a rádioterapia $2 mesh $3 sllk_un_auth*d011878 $9 .
    610
    2-
    $a chemoterapia indukčná
    610
    2-
    $a nádor pokročilý neresekovateľný
    610
    2-
    $a toxicita chemoterapie
    675
      
    $a 616.24-006.6-085 $v 2. $z slo
    701
    -1
    $a Lee $b H.-W. $3 sllk_un_auth*p0045859 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Choi $b J.-H. $3 sllk_un_auth*p0045861 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Lim $b H.-Y $3 sllk_un_auth*p0045862 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Park $b J. S. $3 sllk_un_auth*p0045863 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kim $b H. C. $3 sllk_un_auth*p0045864 $4 070 $p Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Kang $b S. $3 sllk_un_auth*p0045865 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Oh $b Y. T. $3 sllk_un_auth*p0045866 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Chun $b M. $3 sllk_un_auth*p0045867 $4 070 $p Radiation Oncology, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Sheen $b S. S. $3 sllk_un_auth*p0045868 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Oh $b Y. J. $3 sllk_un_auth*p0045869 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Park $b K. J. $3 sllk_un_auth*p0045870 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea
    701
    -1
    $a Hwang $b S. C. $3 sllk_un_auth*p0045871 $4 070 $p Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea
    801
    -0
    $a SK $b BA006 $c 20061023 $g AACR2


  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.